CONMED (CNMD) EVP Brent Lalomia reports 401(k) share acquisitions

Rhea-AI Filing Summary

CONMED Corporation executive Brent Lalomia, Executive VP RA, QA, reported annual changes in indirect ownership of CONMED common stock for the fiscal year ended 12/31/2025. Between January 1, 2025 and December 31, 2025, he acquired 31.626 shares of CNMD common stock through the company’s 401(k) plan at a reported price of $40.6 per share. As of December 31, 2025, his 401(k) plan held a total of 125.232 shares of CONMED common stock, reported as indirectly owned. No derivative securities were reported.

SEC Form 5

FORM 5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0362
Estimated average burden
hours per response:			1.0

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Form 3 Holdings Reported.

Form 4 Transactions Reported.

1. Name and Address of Reporting Person^*

Lalomia Brent

(Last) (First) (Middle)

C/O CONMED CORPORATION

11311 CONCEPT BOULEVARD

(Street)

LARGO FL 33773

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CONMED Corp [ CNMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive VP RA, QA

3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
				Amount	(A) or (D)	Price
Common Stock	12/31/2025(1)		J	31.626	A	$40.6	125.232(2)	I	401 (K) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
					(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. As of December 31, 2025.

2. Between January 1, 2025 and December 31, 2025, the reporting person acquired 31.626 shares of CNMD common stock under the CNMD 401(k) plan. The information in this report is based on a plan statement dated as of December 31, 2025.

	/s/ Thomas Fistek for Brent Lalomia by Power of Attorney	01/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did CNMD report for Brent Lalomia in this Form 5?

The filing reports that Brent Lalomia, Executive VP RA, QA of CONMED Corporation (CNMD), acquired additional common stock during 2025 through the company’s 401(k) plan and discloses his indirectly owned balance as of December 31, 2025.

How many CNMD shares did Brent Lalomia acquire in 2025 under the 401(k) plan?

Between January 1, 2025 and December 31, 2025, Brent Lalomia acquired 31.626 shares of CONMED common stock under the CNMD 401(k) plan, according to the plan statement dated as of December 31, 2025.

What is Brent Lalomia’s CNMD share balance in the 401(k) plan at year-end 2025?

As of December 31, 2025, the 401(k) plan account associated with Brent Lalomia held 125.232 shares of CONMED common stock, reported as indirect ownership on the Form 5.

At what price were the CNMD shares reported as acquired on the Form 5?

The Form 5 lists a transaction on 12/31/2025 coded as "J" for 31.626 shares of CONMED common stock at a price of $40.6 per share, reflecting the 401(k) plan activity.

Does this CNMD Form 5 report any derivative securities for Brent Lalomia?

No. Table II for derivative securities shows no entries, indicating that no options, warrants, or other derivative securities were reported for Brent Lalomia for the fiscal year ended December 31, 2025.

Is Brent Lalomia a director or large shareholder of CNMD according to this filing?

According to the filing, Brent Lalomia is reported as an officer of CONMED Corporation with the title Executive VP RA, QA, and he is not marked as a director or a 10% owner.